Biomarker for cardiac aging;  proposed to play a major role in the onset of cardiovascular disease;  depletion of MCP1 from the blood using the anti-MCP1 antibody Carlumab did not result in a permanent decrease in MCP1 serum levels. Here, CCL2 is linked to cardiovascular disorder.